However, triggering TCRs can enhance PD-1 expression and, subsequently, PD-L1 expression by targeted tumor cells, which turns off antitumor T-cell responses, a phenomenon known as T-cell exhaustion [155]. The gene discussed is CD274; the disease is neoplasm.